¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Other specified effects of reduced temperature"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® basal body temperature ÇÑ±Û ±âÃÊü¿Â
¼³¸í   
  À½½Ä-¿îµ¿-Á¤½Å°¨µ¿ µî Ã¼¿Â¿¡ ¿µÇâÀ» ÁÙ ¸¸ÇÑ ¿©·¯ Á¶°ÇÀ» ÇÇÇÏ¿© ¸ö°ú ¸¶À½ÀÌ ¾ÈÁ¤µÇ¾úÀ» ¶§ Àé Ã¼¿Â, º¸Åë ¾ÆÄ§¿¡ ´«À» ¶á Á÷ÈÄ¿¡ Àç¸ç, ¿©¼ºÀÇ °æ¿ì ¿ù°æ Áֱ⿡ µû¶ó ´Þ¶óÁö¹Ç·Î ¼öÅ Á¶ÀýÀ̳ª ÀÚ±Ã, ³­¼ÒÀÇ º´ Áø´Ü¿¡ ÀÀ¿ëÇÑ´Ù. 6~8½Ã°£ÀÇ ¾ÈÁ¤µÈ ¼ö¸éÀ» ÃëÇÑ ÈÄ ¾ÆÄ§ ÀÏÂï ±ú¾î³ª, ÀáÀÚ¸®¿¡¼­ ³ª¿À±â Àü¿¡ Ã¼¿Â°è¸¦ ÀÔ¿¡ ¹°¾î¼­ ÃøÁ¤ÇÑ´Ù. ¹Ì¹¦ÇѠü¿ÂÀÇ Â÷À̸¦ ÃøÁ¤Çϴ °ÍÀ̹ǷΠ¿©¼ºÃ¼¿Â°è¸¦ »ç¿ëÇϴ °ÍÀÌ ÁÁ´Ù. ÀÌ ¿©¼ºÃ¼¿Â°èÀÇ ¼öÀº±¸ºÎ¸¦ ÇôÀÇ ¾Æ·§¸é¿¡ ³¢¿ì°í¼­ ÀÔÀ» °¡º±°Ô ´Ù¹°°í ¾à 5ºÐ µ¿¾È ÀÖ´Ù°¡ ÃøÁ¤Çϸ頵ȴÙ. Á¤»óÀûÀΠ±âÃÊü¿ÂÀº º¹ÀâÇÑ ¼ºÁÖ±âÀÇ º¯È­¸¦ º¸À̱⠶§¹®¿¡ ¿ù°æÁֱ⿡ °üÇÑ °¢Á¾ Áø´ÜÀ» ºñ·ÔÇÏ¿© ÀÓ½Å-À¯»ê-ÀÌ»óÀÓ½ÅÀÇ Áø´Ü°ú ¼öÅÂÁ¶Àý µî¿¡ ÀÀ¿ëÇϴ µî ¿©·¯ °¡Áö È¿°úÀûÀΠÀÚ·á°¡ µÈ´Ù.
¿µ¹® side effects of drugs ÇÑ±Û ¾à¹°ÀÇ ºÎÀÛ¿ë
¼³¸í   
  ¾àÀ» »ç¿ëÇÒ ¶§ ±â´ëÇϴ ȿ°ú ¿Ü¿¡ ´Ù¸¥ Àå±â¿¡¼­ ³ªÅ¸³ª´Â ¿øÄ¡ ¾Ê´Â È¿°ú¸¦ ÃÑĪÇϴ ¸»ÀÌ´Ù. ¿¹¸¦ µé¾î Ç÷¾ÐÀ» ³·Ãß±â À§ÇØ Ç×°íÇ÷¾ÐÁ¦¸¦ »ç¿ë ½Ã, Ç÷¾ÐÀÌ ¶³¾îÁö´Â µ¿½Ã¿¡ ±â°üÁöÀÇ ¼öÃàÀÌ ÀϾ´Â Çö»ó.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced bandwidth technique
    Á֯ļöÆø°¨¼Ò±â¹ý
  • reduced flavoprotein
    ȯ¿øÇüÇöóºó´Ü¹éÁú
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò, ȯ¿øÇì¸ð±Û·Îºó
  • reduced pelvis
    Ãà¼Ò°ñ¹Ý
  • reduced penetrance
    °¨Åð¹ßÇö
  • axillary temperature
    °Üµå¶ûü¿Â, ¾×¿Íü¿Â
  • absolute temperature
    Àý´ë¿Âµµ
  • basal body temperature
    ±âÃÊü¿Â
  • body temperature
    ü¿Â
  • core temperature
    Áß½Éü¿Â, ½ÉºÎü¿Â
  • critical temperature
    ÀÓ°è¿Âµµ
  • effective temperature chart
    °¨°¢¿ÂµµÇ¥
  • effective temperature index
    À¯È¿¿ÂµµÁö¼ö
  • high temperature sterilization
    °í¿Â¸ê±Õ
  • low temperature resin
    Àú¿Â¼öÁö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò
  • temperature
    ¿Âµµ
  • basal body temperature
    ±âÃÊü¿Â
  • body temperature
    ü¿Â
  • core temperature
    ½ÉºÎü¿Â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced flavoprotein
    ȯ¿øÇüÇöóºó´Ü¹éÁú
  • reduced heat
    ȯ»ê¿­·®
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò
  • reduced pelvis
    ÇùÂø°ñ¹Ý, Ãà¼Ò°ñ¹Ý
  • reduced penetrance
    °¨Åð¹ßÇö
  • reduced bandwidth technique
    Á֯ļöÆø°¨¼Ò±â¹ý
  • absolute temperature
    Àý´ë¿Âµµ
  • annealing temperature
    ºÙÀӿµµ
  • basal body temperature
    ±âÃÊü¿Â
  • body temperature
    ü¿Â
  • body temperature ambient pressure saturation
    ü¿Â´ë±â¾Ð¼öÁõ±âÆ÷È­»óÅÂ
  • temperature blanket
    ü¿ÂÁ¶Àý´ã¿ä
  • core body temperature
    ½ÉºÎü¿Â
  • effective temperature chart
    °¨°¢¿ÂµµÇ¥
  • temperature controller
    ¿ÂµµÁ¶Àý±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced body temperature
    Àúü¿Â(¹ý) (î¸ô÷è®Ûö).
  • reduced temperature
    Àú¿Â(î¸è®).
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • BBT=£¾ basal body temperature
    ±âÃÊü¿Â.
  • Curie temperature
    Å¥¸® ¿Âµµ
  • abnormal temperature
    ÀÌ»ó¿Âµµ, ÀÌ»óü¿Â(~ü¿Â).
  • ambient temperature
    ½Ç¿Â(ËàËí).
  • ambient temperature and pressure saturated with water vapor =ATP
    ½Ç¿Â´ë±â¾Ð ¼öÁõ±â Æ÷È­»óÅÂ
  • high temperature sterlization
    °í¿Â¸ê±Õ.
  • house hold temperature
    ¿Á³»¿Âµµ.
  • platinum temperature
    ¹é±Ý¿Âµµ(¡­è®öô ).
  • regulation of body temperature
    ü¿ÂÁ¶Àý(ô÷è®ðàï½).
  • Gullstrands reduced eye
    ±¼½ºÆ®¶õµå»ý·«¾È
  • reduced bandwidth technique
    Á֯ļöÆø °¨¼Ò ±â¹ý
  • reduced eye
    »ý·«¾È(ßèå²äÑ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • specified disease
    ƯÁ¤µÈ Áúº´(÷åïÒ¡­òðÜ»), ƯÀÌÁúȯ(÷åì¶òðü´)
  • reduced body temperature
    Àúü¿Â(¹ý) (î¸ô÷è®Ûö).
  • reduced temperature
    Àú¿Â(î¸è®).
  • temperature reduced
    Àú¿Â(î¸è®).
  • atypical, mixed or other personality
    ºñÁ¤Çü ³»Áö È¥ÀçÇü ¶Ç´Â ±âŸ ÀΰÝ
  • shock and other somatic treatment
    Ãæ°Ý ¹× ±âŸ ½Åüġ·á
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • autonomic side effects
    ÀÚÀ²½Å°æ°è ºÎÀÛ¿ë
  • behavioral side effects
    ÇൿºÎÀÛ¿ë
  • biologic effects
    »ý¹°ÇÐÀû È¿°ú (ßæÚªùÊîÜ üùÍý)
  • biological effects
    »ý¹°ÇÐÀû È¿°ú (ßæÚªùÊîÜ üùÍý)
  • drugs,side effects
    ºÎÀÛ¿ë(ÜùíÂéÄ)
  • period effects
    ±â°£ È¿°ú
  • side effects
    ºÎÀÛ¿ë(ÜùíÂéÄ).
  • signal effects
    ½Åȣȿ°ú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced mean residue rotation
    ȯ»ê Æò±Õ Àܱâ ȸÀü(üµß©øÁгíÑÐñüÞï®)
  • reduced osmotic pressure
    ȯ»ê »ïÅõ¾Ð(üµß©ß¶÷âäâ)
  • reduced scattered light intensity
    ȯ»ê »ê¶õ±¤ °­µµ(üµß©ß¤Õ¯ÎÃË­Óø)
  • reduced substrate concentration
    ȯ»ê ±âÁú ³óµµ(üµß©Ñ¨òõÒØÓø)
  • reduced viscosity
    ȯ»ê Á¡µµ(üµß©ïÄÓø)
  • absolute temperature
    Àý´ë¿Âµµ (ï¾Óßè®Óø)
  • critical temperature
    ÀÓ°è ¿Âµµ(×üÍ£è®Óø)
  • high-temperature protection regulon
    °í¿Âº¸È£(ÍÔè®ÜÁûÞ) ·¹±Ö·Ð
  • high-temperature-short-time method
    °í¿Â ´Ü½Ã°£¹ý(ÍÔè®Ó­ãÁÊàÛö)
  • Kelvin temperature scale
    Ä̺ó¿Âµµ(è®Óø) ´«±Ý
  • Krafft temperature
    Å©¶óÇÁÆ®¿Âµµ(è®Óø)
  • low-temperature heat method
    Àú¿Â¿­¹ý(î¸è®æðÛö)
  • melting temperature
    À¶Çؿµµ(ë×ú°è®Óø)
  • optimum temperature
    ÃÖÀû¿Âµµ(õÌîêè®Óø)
  • solid substrate room temperature phosphorescence
    °íü±âÁú ½Ç¿ÂÀα¤¹ý(ͳô÷Ðñòõ ãøè®ìÝÎÃÛö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • side effects
    ºÎÀÛ¿ë
  • absolute temperature
    Àý´ë¿Âµµ
  • Curie temperature
    Å¥¸®¿Âµµ
  • reduced
    °¨ÅðÇÑ
  • reduced bandwidth technique
    ´ëÆø°¨¼Ò±â¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ad add [Lat. adde] let there be added [up to a specified amount] [Lat. addetur]; axiodistal; right ear ...
NES not elsewhere specified
NOS network operating system; nitric oxide synthetase; non-organ-specific; not on staff; not otherwise s...
NS natural science; Neosporin; nephrosclerosis; nephrotic syndrome; nervous system; neurological surger...
BTC basal temperature chart; body temperature chart
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EDNOS Eating Disorder Not Otherwise Specified
NOS Not Otherwise Specified
PDD-NOS Pervasive Developmental Disorder Not Otherwise Specified
SPF specified pathogen free
DRO Differential Reinforcement of Other Behaviour
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • T69.8
    Other specified effects of reduced temperature
    ±âŸ ¸í½ÃµÈ ÀúÇÏµÈ ¿ÂµµÀÇ ¿µÇâ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute and late normal tissue effects£¨Á¤»ó Á¶Á÷ ±Þ¼º ¿µÇ⣩

    acute angle

    ¿¹°¢
    Á÷°¢º¸´Ù ÀÛÀº °¢.
  • reduced
    °¨ÅðÇÑ
    1. °ñÀýÀÇ Á¤º¹°ú °°ÀÌ ÀûÀýÇÑ À§Ä¡, ¹èÄ¡¿¡ µÇµ¹¸°. 2. ±Ý¼ÓÀÇ ÇüÀ¸·Î µÇµ¹¸°.
  • reduced dental epethelium
    ÅðÃà Ä¡»óÇÇ
  • reduced interoccusal distance
    ÀúÀ§ ±³ÇÕ
  • form-other
    Çü½Ä»óÀÇ ¸ñ
  • other abnormality
    ±âŸ ÀÌ»ó
  • other craniofacial disorder
    ´Ù¸¥ µÎ°³ ¾È¸é Àå¾Ö
  • other facial structure
    ´Ù¸¥ ¾È¸é ±¸Á¶¹°
  • other mycoses
    ±âŸ Áø±ÕÁõ
  • atmospheric temperature and pressure
    ´ë±â Ç¥ÁØ »óÅÂ
  • basal body temperature
    ±âÃÊ Ã¼¿Â
  • body temperature ambient pressure satur
    ü¿Â ´ë±â¾Ð ¼öÁõ±â Æ÷È­ »óÅÂ
  • casting temperature
    ÁÖÁ¶ ¿Âµµ
    ¸Å¸ôÀç ³»ºÎÀÇ ÁÖÁ¶Çü ¿Âµµ°¡ ÃæºÐÈ÷ ³ô¾Æ¼­ ¸Å¸ôµÈ ³³ ¿øÇüÀÌ ¿ÏÀüÈ÷ ¼ÒȯµÇ°í ¿ëÀ¶µÈ ÇÕ±ÝÀÌ À¯µ¿¼ºÀÇ ¾×ü »óÅ·ΠÁøÀÔÇϴµ¥ ¿ä±¸µÇ´Â ¿ÂµµÀÌ´Ù.
  • color temperature
    »ö ¿Âµµ
  • constant temperature
    Ç׿Â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
other-directed Pertaining to a person readily influenced by the attitudes of others.
(05 Mar 2000)
transferases (other substituted phosphate groups) <enzyme> A class of enzymes that transfers substituted phosphate groups.
Registry number: EC 2.7.8
(12 Dec 1998)
cumulative effects Effects on the environment resulting from actions that are individually minor but that add up to a greater total effect as they take place over a period of time.
(05 Dec 1998)
prenatal exposure delayed effects Delayed effects on offspring of maternal or foetal prenatal exposure to drugs, radiation and other physical agents, manipulation, nutrition, stress, etc.
(12 Dec 1998)
side effects Problems that occur when treatment affects healthy cells. Common side effects of cancer treatment are fatigue, nausea, vomiting, decreased blood cell counts, hair loss, and mouth sores.
(12 Dec 1998)
diamagnetic effects <radiobiology> Application of a magnetic field to a plasma will tend to create circulating current within the plasma that will reduce the strength of the magnetic field.
(09 Oct 1997)
experimenter effects The influence of the experimenter's behaviour, personality traits, or expectancies on the results of that person's own research.
See: double blind study.
(05 Mar 2000)
foetal alcohol effects A softer diagnosis than foetal alcohol syndrome (FAS). The diagnosis of possible FAE is considered when: 1. The person has some signs of FAS; 2. The person does not meet all of the necessary criteria for FAS; and 3. There is a history of alcohol exposure before birth.
(12 Dec 1998)
reduced enamel epithelium The several layers of the enamel organ remaining on the enamel surface after formation of enamel is completed.
Synonym: reduced enamel epithelium.
(05 Mar 2000)
reduced eye A simplified design of the ocular optical system, represented as having a single refracting surface and a uniform index of refraction; a model based on this concept is used in retinoscopy and ophthalmoscopy.
(05 Mar 2000)
reduced glutathione Glutathione acting as a hydrogen donor.
(05 Mar 2000)
reduced haematin 1. <biochemistry> Compounds of iron complexed in a porphyrin (tetrapyrrole) ring that differ in side chain composition. Haems are the prosthetic groups of cytochromes and are found in most oxygen carrier proteins.
2. <prefix> haem-, eaning relating to blood.
Origin: G. Haima
(21 Jun 2000)
reduced haemoglobin The form of Hb in red blood cells after the oxygen of oxyhemoglobin is released in the tissues.
(05 Mar 2000)
reduced interarch distance An occluding vertical dimension which results in an excessive interocclusal distance when the mandible is in rest position, and in a reduced interridge distance when the teeth are in contact.
(05 Mar 2000)
Listing's reduced eye A representation that simplifies calculations of retinal imagery: radius of anterior refracting surface, 5.1 mm; total length, 20 mm; distance of nodal point to retina, 15 mm.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced
    ÁÙÀÎ;Ãà¼ÒÇÑ;°¨¼ÒÇÑ;ÇÒÀÎÇÑ;¿µ¶ôÇÑ;¸ô¶ôÇÑ;¼è¾àÇÑ;ȯ¿øÇÑ;±â¾àÀÇ
  • household effects
    °¡Àç µµ±¸
  • personal effects
    ¼ÒÁöǰ
  • sound effects
    À½ÇâÈ¿°ú
  • temperature
    ¿Âµµ
  • Curie point (temperature)
    Äû¸®Á¡(¿Âµµ)(Àڱ⠺¯Å°¡ ÀϾ´Â ¿Âµµ)
  • absolute temperature
    Àý´ë ¿Âµµ
  • color temperature
    »ö¿Âµµ
  • critical temperature
    ÀÓ°è ¿Âµµ
  • normal temperature
    Æò»óü¿Â
  • room temperature
    (Åë»óÀÇ)½Ç³» ¿Âµµ(20µµÁ¤µµ)
  • temperature
    ¿Âµµ;ü¿Â;run a ~ ¿­ÀÌ ÀÖ´Ù;¿­À» ³»´Ù;ÈïºÐÇÏ´Ù;take one's ~ ü¿ÂÀ» Àç´Ù
  • each other
    ¼­·Î
  • in some way or other
    ¾î¶»°Ô ÇØ¼­µçÁö
  • other
    ±×¹ÛÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á